- recruitingPhase III and phase IV (Integrated)
Aspirin in immune thrombocytopenia patients with cardiovascular disease
This study is looking at how a small dose of aspirin affects blood clotting in people with a condition called immune thrombocytopenia, who also have heart or circulation problems. They want to see how aspirin changes a specific chemical in the blood related to clotting.
France - recruitingPhase I and Phase II (Integrated)- Other
An Adaptive, Open-Label, Dose-Finding, Phase 1/2 Study Investigating the Safety, Pharmacokinetics, and Clinical Activity of Rilzabrutinib (PRN1008), an Oral BTK Inhibitor, in Patients with Relapsed Immune Thrombocytopenia
This study is testing a new oral medicine, Rilzabrutinib, for adults with a blood condition called Immune Thrombocytopenia (ITP). It aims to see if the medicine is safe, how much to give, and if it helps increase platelet counts to reduce bleeding.
Czechia · Netherlands · Bulgaria - recruitingPHASE3
Study to Evaluate the Efficacy and Safety of Oral Rilzabrutinib in Adults With Immune Thrombocytopenia (ITP) Who Failed First-line Treatment
This study is for adults with a blood condition called Immune Thrombocytopenia (ITP) who haven't responded well to their first treatment. It looks at a new medicine called rilzabrutinib to see how well it works and if it's safe. It's a Phase 3 trial, meaning it's in a later stage of testing.
United States · Austria · France - recruitingPHASE1
Safety and Efficacy of GL-2045 in Patients With Immune Thrombocytopenia
This study is looking at a new medicine called GL-2045 for people with Immune Thrombocytopenia (ITP). The main goal is to see if it's safe and helps increase platelet counts, similar to a treatment called IVIg.
United Kingdom - recruitingPHASE2
Study to Assess the Safety and Tolerability of Tafasitamab in Adult Participants With Primary Autoimmune Blood Cell Disorders
This study is looking at a new treatment called tafasitamab for adults with a type of autoimmune blood disorder called Immune Thrombocytopenia. Researchers want to see if it's safe, how well it works, and if it could be a helpful option for patients.
United States · Australia · France - active not recruitingPHASE3
Study to Evaluate Rilzabrutinib in Adults and Adolescents With Persistent or Chronic Immune Thrombocytopenia (ITP)
This study tested a new medicine, rilzabrutinib, for adults and teenagers with a blood condition called Immune Thrombocytopenia (ITP). It aimed to see if the medicine could help increase platelet counts, which are important for stopping bleeding.
United States · Argentina · Australia - active not recruitingPHASE1, PHASE2
An Open-label Study of Povetacicept in Participants With Autoimmune Cytopenias
This study looks at a new medicine called povetacicept for adults with rare blood conditions like Immune Thrombocytopenia (ITP), Warm Autoimmune Hemolytic Anemia (wAIHA), and Cold Agglutinin Disease (CAD). Researchers want to see if it's safe and helps improve these conditions.
United States · Australia · Austria